Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew X Zhang

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
ACS Synthetic Biology|April 4, 2018
Modulating Antibody Structure and Function through Directed Mutations and Chemical RescueChristine E Kaiser, Juan Pablo Rincon Pabon, Jittasak Khowsathit, et al.
International Journal of Molecular Sciences|June 28, 2023
Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational ModificationsGhaith M Hamza, Eric Miele, Don M Wojchowski, et al.
Chembiochem : a European Journal of Chemical Biology|January 27, 2023
EFMC: Trends in Medicinal Chemistry and Chemical BiologyYves P Auberson, Paola B Arimondo, Maria Duca, et al.
ACS Chemical Biology|January 5, 2023
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized HitAarti Kawatkar, Roger A Clark, Lorna Hopcroft, et al.
Communications Biology|September 19, 2024
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymesJonathan D Taylor, Nathalie Barrett, Sergio Martinez Cuesta, et al.
Chemmedchem|April 4, 2017
Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2Matias Casás-Selves, Andrew X Zhang, James E Dowling, et al.
Journal of Medicinal Chemistry|July 22, 2021
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple MyelomaDavid E Uehling, Babu Joseph, Kim Chan Chung, et al.
Journal of Medicinal Chemistry|January 16, 2024
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b InhibitorsAdelphe M Mfuh, Jeffrey A Boerth, Gayathri Bommakanti, et al.
Journal of Medicinal Chemistry|September 27, 2021
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPsJeffrey W Johannes, Amber Balazs, Derek Barratt, et al.
Journal of Medicinal Chemistry|December 10, 2024
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective InhibitorJeffrey W Johannes, Amber Y S Balazs, Derek Barratt, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
ACS Synthetic Biology|April 4, 2018
Modulating Antibody Structure and Function through Directed Mutations and Chemical RescueChristine E Kaiser, Juan Pablo Rincon Pabon, Jittasak Khowsathit, et al.
International Journal of Molecular Sciences|June 28, 2023
Affi-BAMS™: A Robust Targeted Proteomics Microarray Platform to Measure Histone Post-Translational ModificationsGhaith M Hamza, Eric Miele, Don M Wojchowski, et al.
Chembiochem : a European Journal of Chemical Biology|January 27, 2023
EFMC: Trends in Medicinal Chemistry and Chemical BiologyYves P Auberson, Paola B Arimondo, Maria Duca, et al.
ACS Chemical Biology|January 5, 2023
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized HitAarti Kawatkar, Roger A Clark, Lorna Hopcroft, et al.
Communications Biology|September 19, 2024
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymesJonathan D Taylor, Nathalie Barrett, Sergio Martinez Cuesta, et al.
Chemmedchem|April 4, 2017
Target Deconvolution Efforts on Wnt Pathway Screen Reveal Dual Modulation of Oxidative Phosphorylation and SERCA2Matias Casás-Selves, Andrew X Zhang, James E Dowling, et al.
Journal of Medicinal Chemistry|July 22, 2021
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple MyelomaDavid E Uehling, Babu Joseph, Kim Chan Chung, et al.
Journal of Medicinal Chemistry|January 16, 2024
Discovery, Optimization, and Biological Evaluation of Arylpyridones as Cbl-b InhibitorsAdelphe M Mfuh, Jeffrey A Boerth, Gayathri Bommakanti, et al.
Journal of Medicinal Chemistry|September 27, 2021
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPsJeffrey W Johannes, Amber Balazs, Derek Barratt, et al.
Journal of Medicinal Chemistry|December 10, 2024
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective InhibitorJeffrey W Johannes, Amber Y S Balazs, Derek Barratt, et al.
Pageof 3